Pfizer Inc.

Invetso

AAPL: $198.85 ▲ 15.33%

GOOGL: $158.71 ▲ 9.68%

MSFT: $390.49 ▲ 10.13%

AMZN: $191.10 ▲ 11.98%

TSLA: $272.20 ▲ 22.69%

NFLX: $945.47 ▲ 8.62%

ADBE: $364.64 ▲ 7.25%

INTC: $21.53 ▲ 18.75%

AMD: $96.84 ▲ 23.82%

AAPL: $198.85 ▲ 15.33%

GOOGL: $158.71 ▲ 9.68%

MSFT: $390.49 ▲ 10.13%

AMZN: $191.10 ▲ 11.98%

TSLA: $272.20 ▲ 22.69%

NFLX: $945.47 ▲ 8.62%

ADBE: $364.64 ▲ 7.25%

INTC: $21.53 ▲ 18.75%

AMD: $96.84 ▲ 23.82%

AAPL: $198.85 ▲ 15.33%

GOOGL: $158.71 ▲ 9.68%

MSFT: $390.49 ▲ 10.13%

AMZN: $191.10 ▲ 11.98%

TSLA: $272.20 ▲ 22.69%

NFLX: $945.47 ▲ 8.62%

ADBE: $364.64 ▲ 7.25%

INTC: $21.53 ▲ 18.75%

AMD: $96.84 ▲ 23.82%

AAPL: $198.85 ▲ 15.33%

GOOGL: $158.71 ▲ 9.68%

MSFT: $390.49 ▲ 10.13%

AMZN: $191.10 ▲ 11.98%

TSLA: $272.20 ▲ 22.69%

NFLX: $945.47 ▲ 8.62%

ADBE: $364.64 ▲ 7.25%

INTC: $21.53 ▲ 18.75%

AMD: $96.84 ▲ 23.82%

New York Stock Exchange:

PFE

$22.49

+0.65 (2.98%)

At close: Thu, Apr 10, 2025, 16:00

Ticker

PFE

Market Cap

127.55 B

Revenue

NaN B

EPS

1.41

PE Ratio

15.95

Volume

95,160,761

Dividend

1.69%

Week Range

20.91 - 22.54

Beta

0.60

Frameworks

Name

Score

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Pfizer Inc.

Country

Founded

1972

IPO Date

June 1, 1972

Industry

Drug Manufacturers - General

Employees

81,000

CEO

Dr. Albert Bourla D.V.M., Ph.D.

Top News

Proxy adviser ISS recommends Pfizer shareholders to vote against CEO compensation

Institutional Shareholder Services is recommending Pfizer's investors to reject a management proposal on annual compensation for CEO Albert Bourla and other executives, the proxy adviser said on Wednesday.

Stocks: PFE 4/2/2025, 9:10:34 AM reuters.com

Wall Street Says Sell US Market Rallies: Never Sell These 4 High-Yield Dividend Giants

The “buy the dip” strategy worked flawlessly for over two years.

Stocks: PFE 4/2/2025, 7:47:18 AM 247wallst.com

2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating

When Wall Street analysts decide to come out of their caves and boost a certain stock, retail investors should pay attention to the motives behind the decision as it can signal a shift in sentiment toward an entire sector.

Stocks: PFE 4/1/2025, 7:49:55 PM marketbeat.com